Integral Diagnostics Limited (ASX:IDX)
Australia · Delayed Price · Currency is AUD 2.140
+0.020 (0.94%)
Oct 7, 2026, 4:10 PM AEST
Integral Diagnostics Market Cap
Integral Diagnostics has a market cap or net worth of 797.13 million as of October 7, 2026. Its market cap has decreased by -21.08% in one year.
Market Cap
797.13M
Enterprise Value
1.35B
Revenue
788.62M
Ranking
n/a
PE Ratio
36.90
Stock Price
2.14
ChartMarket Cap Chart
Since October 21, 2015, Integral Diagnostics's market cap has increased from 263.77M to 797.13M, an increase of 202.21%. That is a compound annual growth rate of 10.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 797.13M | -15.80% |
| Dec 31, 2025 | 946.69M | -12.49% |
| Dec 31, 2024 | 1.08B | 143.25% |
| Dec 29, 2023 | 444.76M | -34.84% |
| Dec 30, 2022 | 682.57M | -31.87% |
| Dec 31, 2021 | 1.00B | 16.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sonic Healthcare | 9.12B |
| Australian Clinical Labs | 516.28M |
| Healius | 286.83M |
| Monash IVF Group | 286.38M |
| Cryosite | 56.13M |
| Microba Life Sciences | 34.32M |
| BCAL Diagnostics | 32.08M |
| Rhythm Biosciences | 28.31M |